Seeing Is Believing
Biotechnology & Medical Research - Industry
OncoSec Medical's activity chart (see below) currently has 2 price targets and 2 ratings on display.
Analysts average stock forecasts to be materialized ratio is 40% with an average time for these price targets to be met of 348.8 days.
Most recent stock forecast was given by JASON KOLBERT from DAWSON JAMES on 17-Mar-2022.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 27-Jul-2020
$220
4 years 3 months 21 days ago
(17-Mar-2022)
0/1 (0%)
$147.4 (203.03%)
Buy Since 31-Jul-2019
$12
$12 (0.00%)
$6
5 years 3 months 13 days ago
(25-Mar-2021)
2/2 (100%)
$-105.7 (-89.80%)
872
Buy Since 12-Dec-2018
$660
6 years 8 months 28 days ago
(10-Oct-2019)
0/1 (0%)
$480.92 (268.55%)
What is ONCS (OncoSec Medical) average time for price targets to be met?
Which analyst has the current highest performing score on ONCS (OncoSec Medical) with a proven track record?
Which analyst has the current lower performing score on ONCS (OncoSec Medical) with a proven track record?
Which analyst has the most public recommendations on ONCS (OncoSec Medical)?
Which analyst is the currently most bullish on ONCS (OncoSec Medical)?
Which analyst is the currently most reserved on ONCS (OncoSec Medical)?